1. Home
  2. ALZN vs YGMZ Comparison

ALZN vs YGMZ Comparison

Compare ALZN & YGMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • YGMZ
  • Stock Information
  • Founded
  • ALZN 2016
  • YGMZ 2002
  • Country
  • ALZN United States
  • YGMZ China
  • Employees
  • ALZN N/A
  • YGMZ N/A
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • YGMZ Transportation Services
  • Sector
  • ALZN Health Care
  • YGMZ Consumer Discretionary
  • Exchange
  • ALZN Nasdaq
  • YGMZ Nasdaq
  • Market Cap
  • ALZN 7.0M
  • YGMZ 5.9M
  • IPO Year
  • ALZN 2021
  • YGMZ 2020
  • Fundamental
  • Price
  • ALZN $1.11
  • YGMZ $0.88
  • Analyst Decision
  • ALZN Strong Buy
  • YGMZ
  • Analyst Count
  • ALZN 1
  • YGMZ 0
  • Target Price
  • ALZN $32.00
  • YGMZ N/A
  • AVG Volume (30 Days)
  • ALZN 174.7K
  • YGMZ 22.0K
  • Earning Date
  • ALZN 12-31-2024
  • YGMZ 01-01-0001
  • Dividend Yield
  • ALZN N/A
  • YGMZ N/A
  • EPS Growth
  • ALZN N/A
  • YGMZ N/A
  • EPS
  • ALZN N/A
  • YGMZ N/A
  • Revenue
  • ALZN N/A
  • YGMZ $89,002,243.00
  • Revenue This Year
  • ALZN N/A
  • YGMZ N/A
  • Revenue Next Year
  • ALZN N/A
  • YGMZ N/A
  • P/E Ratio
  • ALZN N/A
  • YGMZ $11.00
  • Revenue Growth
  • ALZN N/A
  • YGMZ N/A
  • 52 Week Low
  • ALZN $1.06
  • YGMZ $0.86
  • 52 Week High
  • ALZN $15.06
  • YGMZ $6.24
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 34.55
  • YGMZ 26.53
  • Support Level
  • ALZN $1.16
  • YGMZ $1.04
  • Resistance Level
  • ALZN $1.33
  • YGMZ $1.25
  • Average True Range (ATR)
  • ALZN 0.09
  • YGMZ 0.10
  • MACD
  • ALZN 0.01
  • YGMZ -0.02
  • Stochastic Oscillator
  • ALZN 17.86
  • YGMZ 6.33

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About YGMZ MingZhu Logistics Holdings Limited

MingZhu Logistics Holdings Ltd is a Holding company. Its business activities include trucking services and car owner services. Its segments are the trucking business, car owner services business, and liquor distribution business. It generates the majority of its revenue from the trucking segment.

Share on Social Networks: